Viewing Study NCT05708833


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2025-12-31 @ 9:23 PM
Study NCT ID: NCT05708833
Status: TERMINATED
Last Update Posted: 2025-03-13
First Post: 2022-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intra-Osseous Access in Difficult Vascular Access Cases
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Overview

Official Title: Intra-Osseous Access in Difficult Vascular Access Cases
Status: TERMINATED
Status Verified Date: 2025-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Lack of inclusion
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: IODA
Brief Summary: Thousands of peripheral venous accesses are inserted every day all over the world. Some of them, such as those inserted in emergency and / or in critical patients, are absolutely vital. In the particular context of prehospital care, the rate of failure of the first attempt to insert a peripheral venous access has been evaluated at 25%. Success rates of successive attempts were about 75%. Nevertheless, the final success rate is close to 100%.

Failure or delay in obtaining venous access can be life-threatening. Thus, alternatives to peripheral venous access have been proposed including intraosseous route recently made easier by the development of an automated puncture device (EZ-IO®), but still rarely used, especially on conscious patient.

Currently, the place of intraosseous venous access in critical patients is not determined.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: